Scavenger receptor uptake for Fabry disease enzyme replacement therapy

Artificial Red Blood Cell Having Ability to Inhibit Conversion of Hemoglobin into Methemoglobin

RNA construct and methods of use thereof for enhancing the therapeutic effects of cytotoxic cells and stem cells

METHODS AND COMPOSITIONS FOR ATTENUATING GENE EXPRESSION MODULATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES

THERAPEUTIC COMBINATIONS FOR TREATING NEOPLASIA

Methods and compositions for delivering mRNA coded antibodies

Treating Ephrin Receptor A2 (Epha2) Positive Cancer with Targeted Docetaxel-Generating Nano-Liposome Compositions

Pharmaceutical formulations of PEGylated liposomes and blood coagulation factors

Synthetic platelets

POLYNUCLEOTIDE FORMULATIONS FOR USE IN THE TREATMENT OF RENAL DISEASES

Use of polymeric excipients for lyophilization or freezing of particles

Lipid construct for delivery of insulin to a mammal

METHODS FOR USING REGULATORS FOR INCREASING THE EXPRESSION OR ACTIVATION OF P53 AND/OR REGULATORS FOR REDUCING OR INHIBITING THE EXPRESSION OF P63-ALPHA, FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND/OR NON-ALCOHOLIC STEATOHEPATITIS (NASH)

HAAH and MMP-9 are Complementary Cancer Biomarkers and Predictors of Metastasis when Combined

Lipidated PSA compositions and methods

A STERICALLY STABILIZED CARRIER FOR SUBCUTANEOUS, SUBLINGUAL, AND ORAL THERAPEUTICS, COMPOSITIONS AND METHODS FOR TREATING A MAMMAL

Anti-angiogenic therapy based on exosomes derived from menstrual stem cells

MEANS FOR LUNG SPECIFIC DELIVERY

FORMULATIONS AND CARRIER SYSTEMS INCLUDING COMPOUND INTERACTIVE DOMAINS

Ribonucleic acid aptamer having inhibitory effect on non-small cell lung cancer and pharmaceutical composition comprising same

Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections

Multi-Drug Lipsomes to Treat Tumors

Liposome compositions comprising weak acid drugs and uses thereof

Liposome formulation for delivery of Wnt signal pathway inhibitor

COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL

Compounds and compositions for intracellular delivery of therapeutic agents

NUCLEIC ACID VACCINES

SDC-2 exosome compositions and methods of isolation and use

Liposomes comprising a calcium phosphate-containing precipitate

NUCLEIC ACID VACCINES

Chikungunya virus RNA vaccines

Zika virus RNA vaccines

Concatemeric peptide epitope RNAs

Nucleic acid vaccines

Polynucleotide agents targeting programmed cell death 1 ligand 1 (PD-L1) and methods of use thereof

ATP-binding cassette family coding polyribonucleotides and formulations thereof

B CELL-BASED CANCER IMMUNOTHERAPY

Nanoparticle-mediated delivery of cytokines for maintenance of the regulatory T cell phenotype

Recombinant expression vector and lipid membrane structure having said vector encapsulated therein

USES OF ANTI-HER3 ANTIBODIES FOR TREATING CANCER

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES

SYSTEMS FOR TREATING PULMONARY INFECTIONS

Therapeutics for preterm labor management

NANOLIPOSOMES COMPRISING CORTICOSTEROID AS MEDICAMENTS AND METHODS TO PREPARE THEM

Core/shell structure platform for immunotherapy

LIPIDS FOR DELIVERY OF THERAPEUTICS

Delivery method of target material into extracellular vesicles using extracorporeal shockwave

Echinomycin formulation, method of making and method of use thereof

MESOPOROUS SILICA NANOPARTICLES AND SUPPORTED LIPID BI-LAYER NANOPARTICLES FOR BIOMEDICAL APPLICATIONS

TEMSIROLIMUS LIPOSOME AND PREPARATION METHOD THEREOF

Compositions for delivery of drug combinations

Reduced and oxidized polysaccharides and methods of use thereof

NANOSTRUCTURE

Composition containing chlorine dioxide and methods for using same

Liposomal Curcumin for Treatment of Diseases

Modified Polynucleotides for the production of biologics and proteins associated with human disease

Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules

Compounds for targeting drug delivery and enhancing siRNA activity

Lipids and lipid compositions for the delivery of active agents

GM3 functionalized nanoparticles

Stabilizing camptothecin pharmaceutical compositions

Microfluidic mixing devices and systems

Compounds and compositions for intracellular delivery of therapeutic agents

Nanoallergens and uses thereof

Particles comprising a shell with RNA

Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer

ENCAPSULATION OF MESSENGER RNA

Multi-component nanoconstructs

DUAL LOADED LIPOSOMAL NANOPARTICLES

Composition for preventing or treating ischemic diseases, containing liposomes in which VEGF-derived peptides are supported

Compositions and methods for treating HIV-associated neurocognitive disorders

SYSTEMS AND METHODS FOR TARGETED CANCER THERAPIES

RNA INTERFERENCE THERAPEUTICS AGAINST EBOLA VIRUS

LIPOSOMES USEFUL FOR DRUG DELIVERY

Pegylated lipid nanoparticle with bioactive lipophilic compound

Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections

Induction of osteogenesis by delivering BMP encoding RNA

Skin punch biopsy and wound-debridgement training model

Cationic lipids for therapeutic agent delivery formulations

PORCINE IMMUNE MODULATION MODEL

NON-TOXIC VEHICLE TO SOLUBILIZE, DELIVER, AND OBTAIN BIOLOGICAL ACTIVITY OF STEROID HORMONES AT CELL, TISSUE, AND ORGAN TARGETS, IN VITRO AND IN VIVO

Negatively charged self-assembling supported lipid bilayer on mesoporous silica nanoparticles, method of synthesis and use as a nanovector

Compounds and compositions for intracellular delivery of therapeutic agents

Nanolipogel vehicles for controlled delivery of different pharmaceutical agents

Nanoparticulate compositions comprising interferon gamma and losartan for immunotherapy

Fusogenic liposome-coated porous silicon nanoparticles

NANOLIPOSOMAL FORMULATION FOR TARGETING INTEGRIN-LINKED KINASE (ILK) WITH SMALL-INTERFERENCE RNA AND A METHOD FOR TREATING OVARIAN CANCER

Method of painting micro vesicles

Chimeric proteins

Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer

Artificial platelets for treating catastrophic bleeding

USE OF EXOSOMES FOR THE TREATMENT OF DISEASE

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS

Lipid-based drug carriers for rapid penetration through mucus linings

Ophthalmic drug delivery system containing phospholipid and cholesterol

Cleavable lipids

Lipid-derived neutral nanoparticles

Lipid-derived neutral nanoparticles

Liposomes useful for drug delivery

NANOBIOCOMPOSITE COMPOSITIONS AND METHODS

Liposome Compositions Encapsulating Modified Cyclodextrin Complexes and Uses Thereof

Combination liposomal pharmaceutical formulations

HIGH THROUGHPUT OPTIMIZATION OF CONTENT-LOADED NANOPARTICLES

Compositions and methods for delivery of agents

Intracellular pH-responsive fusion peptide and pharmaceutical composition for reducing abnormal prion protein aggregation or misfolding

Serum-stable compositions and methods for light-triggered release of materials

Method for producing liposome and apparatus for producing liposome

Method for producing liposome and apparatus for producing liposome

Combination HIV therapeutic

MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS

NANOCARRIER THERAPY FOR TREATING INVASIVE TUMORS

Topical ophthalmic formulations of endothelin receptor antagonists

Methods and compositions for X-ray induced release from pH sensitive liposomes

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Method for formulating large diameter synthetic membrane vesicles

Platelet-like proteo-microparticles and method of using such in drug delivery

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

COMPOSITIONS AND METHODS FOR THE TREATMENT OF OPHTHALMIC DISEASES AND CONDITIONS

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Targeted liposomal delivery of cGMP analogues

Vesicles formed from block copolymers, and novel block copolymers

Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin

Liposome composition using sugar alcohol with modified surface area and/or porosity as carrier and method for preparing same

Synthetic platelets

METHODS FOR THE TREATMENT OF BLADDER CANCER

Liposome structures and methods of use thereof

Cationic lipid

IMMUNO-REGULATORY LIPID CONTAINING SPHERICAL NUCLEIC ACIDS

Pharmaceutical preparation of carbohydrates for therapeutic use

Compositions and methods to modify cells for therapeutic objectives

Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections

NOVEL RECOMBINANT EXOSOME AND USE THEREOF

Liposomal particles comprising biological molecules and uses thereof

Lipid Nanoparticle Compositions and Methods of Making and Methods of Using the Same

Vesicles comprising epidermal growth factor and compositions thereof

CFTR MRNA compositions and related methods and uses

Compounds for enhancing PPARγ expression and nuclear translocation and therapeutic use thereof

Chikagunya virus RNA vaccines

Compositions and Methods for Treating NLRP3 Inflammasome-Related Diseases and Disorders

Methods for Treating Pancreatic Cancer Using Combination Therapies

Cleavable Lipids

Modified polynucleotides for the production of oncology-related proteins and peptides

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN

Nucleic acid, medical nanoparticle, and pharmaceutical composition thereof

Siloxane-containing phospholipids, compositions and uses thereof

In vivo production of proteins

ENCAPSULATION OF MESSENGER RNA

Methods and devices for liposome preparation by centrifugation

Zika virus RNA vaccines

Liposomes useful for drug delivery

Population Pharmacokinetics of Liposomal Irinotecan

Formulations having anti-inflammatory activity and antimicrobial activity against gram-positive bacteria

Advanced functional biocompatible polymeric matrix containing nano-compartments

Targeted liposomal gemcitabine compositions and methods thereof

AGENT FOR TREATING FIBROSIS OF THE INTESTINE

Antileishmanial compositions and methods of use

Pharmaceutical Formulations of PEGylated Liposomes and Blood Coagulation Factors

LIPOPLEX FORMULATIONS FOR SPECIFIC DELIVERY TO VASCULAR ENDOTHELIUM

Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof

STABLE MICELLE AND/OR LIPOSOME COMPOSITIONS AND USES THEREOF

Method for producing liposome and apparatus for producing liposome

Antigen delivery system

Intravenous formulation and LC/MS/MS analysis method for GMC1

Method for producing liposome

LIPOSOME-BASED MUCUS-PENETRATING PARTICLES FOR MUCOSAL DELIVERY

TARGETED LIPOSOMES ENCAPSULATING IRON COMPLEXES AND THEIR USES

Lipid membrane structure for intracellular delivery of siRNA

Controlled drug release liposome compositions and methods thereof

Lipid vesicle compositions and methods of use

Human lung tissues-active targeting immune nanoliposome of methylprednisolone and a method for producing the same

Methods of improving delivery of compounds for therapy, prophylaxis or diagnosis

Pharmaceutical compositions, preparation and uses thereof

LIPOSOMAL APPARATUS AND MANUFACTURING METHODS

Multivalent fibronectin-integrin binding compositions and methods of use thereof

Ionizable cationic lipids

Lipid nanoparticle compositions and methods for MRNA delivery

Methods and compositions of carrier systems for the purpose of intracellular drug targeting

NOVEL FORMULATION OF PEGYLATED-LIPOSOME ENCAPSULATED GLYCOPEPTIDE ANTIBIOTICS

METHODS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF LIPOSOMAL CHEMOTHERAPY

Nanoparticle-based tumor-targeted drug delivery

Liposomal compositions and uses of same

DELIVERY COMPOSITIONS AND METHODS

Aminoalcohol lipidoids and uses thereof

REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES

POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF

Cancer targeting by anti-EGFR peptides and applications thereof

Method for preparing pH dependent ultra small polymeric nanoparticles for topical and/or transdermal delivery

Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier

Liposomal drug encapsulation

ANTIBIOTIC PROTOCELLS AND RELATED PHARMACEUTICAL FORMULATIONS AND METHODS OF TREATMENT

DRIED FORMULATIONS OF NANOPARTICLE-COATED CAPSULES

Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof

Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications

Method of producing lipid nanoparticles for drug delivery

Compositions and methods for treating ewing sarcoma

MOLECULES AND AGENTS FOR TREATING HEPATITIS B VIRUS

STABLE LIPOSOMAL FORMULATIONS OF ALPHA 2 ADRENERGIC AGONISTS FOR OCULAR DELIVERY

Podophyllotoxin derivatives and their use

Compositions and methods for non-invasive imaging

Supramolecular combinatorial therapeutics

Method for decreasing mortality associated with chronic liver disease by use of long-acting human recombinant soluble tumor necrosis factor α receptor

Method of treating ovarian, tubal and peritoneal cancer

SYNTHETIC PLATELETS

SURFACE CROSS-LINKED LIPIDIC PARTICLES, METHODS OF PRODUCTION AND USES THEREFOR

Methods and compositions for wound treatment

IRINOTECAN HYDROCHLORIDE COMPOSITE PHOSPHOLIPID COMPOSITION, PREPARATION METHOD AND USE THEREOF

Retinoid-lipid drug carrier

Thermosensitive nanoparticle formulations and method of making the same

Compositions and methods relating to proliferative diseases

Liposomes Useful for Drug Delivery

Liposomes useful for drug delivery

Liposomes Useful for Drug Delivery

LIPOSOMAL COMPOSITIONS FOR MUCOSAL DELIVERY

Liposomes useful for drug delivery

STABLE LIPOSOMAL FORMULATIONS OF RAPAMYCIN AND RAPAMYCIN DERIVATIVES FOR TREATING CANCER

Lipid vesicle compositions and methods of use

Transdermal composition for treating pain

Polycomb-associated non-coding RNAs

Nanolipidic particle assembly populations

GM3 functionalized nanoparticles

Method for producing liposome

Reversible Pegylation of Nanocarriers

Liposomes useful for drug delivery to the brain

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS

Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections

Liposomal mupirocin

PEPTIDE-CONJUGATED LIPOSOME

Polycomb-associated non-coding RNAs

Targeting molecule and a use thereof

Treatment of proliferative disorders with a chemiluminescent agent

Compositions and methods for reducing C/EBP homologous protein activity in myeloid-derived suppressor cells

Compounds for targeting drug delivery and enhancing siRNA activity

Compounds for targeting drug delivery and enhancing siRNA activity

Polycomb-associated non-coding RNAS

IN VIVO TARGETING OF CELLS WITH LIGAND-CONJUGATED PARTICLES

Modified polynucleotides for the production of secreted proteins

Methods for treating pancreatic cancer using combination therapies

Reagents and Methods for Treating Cancer

Nanoparticle-mediated delivery of cytokines for maintenance of the regulatory T cell phenotype

Method for formulating large diameter synthetic membrane vesicles

Polycomb-associated non-coding RNAs

Polycomb-associated non-coding RNAs

Anti-cancer compositions and methods

Hybridosomes, compositions comprising the same, processes for their production and uses thereof

FORMULATIONS OF JASMONATES AND NANOCARRIERS OR MICROCARRIERS

TREATMENT OF BREAST CANCER WITH LIPOSOMAL IRINOTECAN

Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers

Liposomes Useful for Drug Delivery

Liposomes Useful for Drug Delivery

ANTIGEN-SPECIFIC IMMUNOTHERAPY USING TOLERIZING LIPOSOMES

Toroidal mesoporous silica nanoparticles (TMSNPs) and related protocells

Nucleic acid vaccines

COMPOSITIONS AND METHODS FOR PROVIDING ACTIVE TELOMERASE TO CELLS IN VIVO

MRNA therapy for pompe disease

Lipids and compositions for intracellular delivery of biologically active compounds

Remote loading of sparingly water-soluble drugs into liposomes

Nucleic acid vaccines

Nanosomal preparation of the complex formed by quercetin (or another flavonol, flavone or a derivative thereof) and 2-hydroxypropyl-beta-cyclodextrin for intravenous use in cerebral pathological conditions

METHOD FOR CONTROLLED RELEASE WITH FEMTOSECOND LASER PULSES

Liposomal particles, methods of making same and uses thereof

MEANS FOR LUNG SPECIFIC DELIVERY

Lipid vesicle compositions and methods of use

Combination therapy for the treatment of ovarian cancer

Liver specific delivery of messenger RNA

Prodrug compositions, prodrug nanoparticles, and methods of use thereof

Cationic lipid

Combination liposomal pharmaceutical formulations

COMPOSITIONS AND METHODS FOR TREATMENT OF RESPIRATORY TRACT INFECTIONS

Dual loaded liposomal pharmaceutical formulations

Combination therapy for treating HER2-positive cancers

Particles comprising a shell with RNA

Bioactive gas-encapsulated echogenic liposomes and methods for treating cardiovascular disease

Compositions and methods for the manufacture of lipid nanoparticles

Liposomal pharmaceutical preparation and method for manufacturing the same

Methods for controlling assembly of lipids on a solid support

LIPOSOME ENCAPSULATED AFFINITY DRUG

Liposome composition for cancer treatment

PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE

POLYMER-GRAFTED NANOBINS

Targeted nano-liposome co-entrapping anti-cancer drugs

Polymeric micelle particle comprising anionic drugs and method of preparing the same

MAGNESIUM-LIPOSOME COMPLEXES

Limit size lipid nanoparticles and related methods

Liposome for topical administration and application thereof

Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells

Tyrosine-based lipids for delivery of therapeutics

Modified polynucleotides for the production of proteins associated with human disease

Method for preparing virosomes

METHODS AND COMPOSITIONS FOR IMPROVING OUTCOMES OF LIPOSOMAL CHEMOTHERAPY

Synthetic nanostructures including nucleic acids and/or other entities

Pharmaceutical composition, preparation and uses thereof

Timed release of substances to treat ocular disorders

Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder

Liposomal drug delivery system for bone cements

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

NOVEL NANOLIPOSOMES AND THEIR USE FOR THE TREATMENT OF AMYLOID PROTEIN DISEASES

PROTEIN VESICLES AND METHODS OF MAKING AND USING THEREOF

Multicompartmental lipid nanoparticles

Modified polynucleotides for the production of proteins